Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$56,548,966
+$26,292,594 QoQ
Shares Held
1,078,767
+96.8% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#39
of 1,033 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Derivatives in GSK
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$55,190
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $1,498,530,307 across 11 Drug Manufacturers - General names. GSK ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
346,498 | $415,600,130 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,086,166 | $389,906,212 | |
| 3 | JNJ |
Johnson & Johnson
|
752,337 | $191,071,027 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
3,093,958 | $178,273,859 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,044,210 | $134,180,985 | |
| 6 | AZN |
Astrazeneca PLC
|
375,473 | $71,197,190 | |
| 7 | GSK |
GSK plc
This page
|
1,078,767 | $56,548,966 | |
| 8 | SNY |
Sanofi
|
634,794 | $27,080,312 |
All Filings in GSK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,548,966 | 1,078,767 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $55,190 | 1,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $30,256,372 | 548,222 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $15,496 | 400 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $5,826,496 | 150,400 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $5,086,528 | 150,400 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $13,528 | 400 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $4,389,571 | 107,377 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,398,619 | 270,094 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $16,033,934 | 432,648 | Shares | Sole | 2024-02-13 | |
| 2023-03-31 | $4,184,990 | 117,622 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $728,979 | 20,745 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $22,702,978 | 771,423 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $15,946,217 | 373,241 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,798,400 | 64,698 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,923,232 | 131,369 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $3,367,982 | 96,215 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,298,827 | 63,691 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,832,513 | 130,901 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,184,543 | 79,600 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||